Omnicell (OMCL) Tops Q2 EPS by 29c; Sees FY Bookings as Low End of Guidance
Get Alerts OMCL Hot Sheet
Revenue Growth %: -1.7%
Financial Fact:
Diluted (in shares): 37.08M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Omnicell (NASDAQ: OMCL) reported Q2 EPS of $0.57, $0.29 better than the analyst estimate of $0.28. Revenue for the quarter came in at $299 million versus the consensus estimate of $284.57 million.
GUIDANCE:
Omnicell sees Q3 2023 EPS of $0.42-$0.52, versus the consensus of $0.45. Omnicell sees Q3 2023 revenue of $290-300 million, versus the consensus of $297.7 million.
Omnicell sees FY2023 EPS of $1.75-$2.00, versus the consensus of $1.68. Omnicell sees FY2023 revenue of $1.16-1.2 million, versus the consensus of $1.18 million. For the full year 2023, the Company expects bookings to trend toward the lower end of the previously disclosed guidance range of $1.000 billion and $1.100 billion.
For earnings history and earnings-related data on Omnicell (OMCL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- lululemon athletica (LULU) Tops Q2 EPS by $1.10, Cuts Guidance
- Broadcom (AVGO) Tops Q3 EPS by 11c, Offers Guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share